Dividend Details
Calculate MRK Dividend Income
Quick Facts
- Yield: 2.69%
- Frequency: Quarterly
- Sector: Healthcare
- Streak: 13 years
About Merck & Co.
Merck & Co. is a global pharmaceutical leader known for blockbuster drugs like Keytruda (cancer immunotherapy) and Gardasil (HPV vaccine), which together generate tens of billions in annual revenue. The company has increased its dividend for 13 consecutive years, backed by the substantial cash flows from its diversified product portfolio. Merck's deep R&D pipeline and track record of successful drug development provide a foundation for continued dividend growth as new therapies reach the market.
13 consecutive years of dividend increases, — the company has raised its payout through recessions, rate hikes, and market downturns alike.
MRK Dividend FAQ
What is MRK's current dividend yield and payout?
MRK currently yields 2.69% annually, paying $3.40 per share per year based on a share price of $126.00. This translates to $0.8500 per share per quarter.
How often does MRK pay dividends?
MRK distributes dividends quarterly, following the standard schedule of most S&P 500 companies. Quarterly payments typically arrive in March, June, September, and December, though exact dates vary. Each payment is approximately $0.8500 per share.
How much does $10,000 invested in MRK pay in dividends?
A $10,000 investment in MRK at $126.00 per share buys approximately 79 shares. At the current 2.69% yield, this generates approximately $269 per year, or $22 per month in dividend income before taxes.
How long has MRK been increasing dividends?
MRK has increased its dividend for 13 consecutive years. This growing track record is a positive sign for income investors.
Is MRK's dividend sustainable?
Evaluate MRK's free cash flow coverage and balance sheet strength from its latest quarterly earnings. A healthy dividend typically has a payout ratio below 75% and growing free cash flow.
MRK Dividend Investing Guide
Merck & Co. (MRK) represents a compelling opportunity for dividend investors seeking balanced yield and growth in their portfolios. As a healthcare sector stock, MRK offers exposure to the healthcare industry with its defensive characteristics and aging population tailwinds.
With 13 consecutive years of dividend increases, MRK has established a solid track record of growing shareholder income. This consistency in dividend growth shows the company can grow its payout while keeping the balance sheet healthy.
To maximize returns from MRK dividends, consider strategies like dividend reinvestment (DRIP) to compound growth over time, tax-efficient account placement for qualified dividends, and portfolio diversification across sectors and payment schedules. Use our DRIP calculator to project long-term growth or our tax calculator to estimate after-tax income from your MRK investment.